Press Coverage

Hepatitis C Treatment: Study Finds No Liver, Kidney or Cardiovascular Adverse Effects

June 10, 2019

Interview mentions that an ISMP QuarterWatch^TM report raising questions about whether direct acting antiviral medications for the treatment of Hepatitis C posed any significant safety risks for patients was the impetus for further study.

For the full text, visit MedicalResearch.com online.

More News

Blog Post 06/28/2019

Medication Safety: A Passion and a Responsibility

As an ISMP fellow, I feel I am contributing to crucial work that supports a safety culture across multiple professions and multiple continents.

Press Coverage 06/18/2019

Guidelines for Flushing IV Lines Between Medications

This article appeared on the Oncology Nurse Advisor website on June 18, 2019.

Other 05/30/2019

IMSN Introduces New Global Targeted Medication Safety Best Practices

An international medication safety call to action is aimed at preventing fatalities due to medication errors with concentrated potassium injection, inadvertent intraspinal injection of vincristine, and accidental daily instead of weekly dosing of methotrexate in patients with psoriasis or rheumatoid arthritis.